• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR Back to Search Results
Catalog Number 486101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Hemorrhage/Bleeding (1888); Pain (1994); Urinary Retention (2119); Urinary Frequency (2275); Dyspareunia (4505); Urinary Incontinence (4572); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: ¿potential adverse reactions are those typically associated with surgically implantable materials, including hematoma, seroma, mucosal or visceral erosion, infection, inflammation, sensitization, dyspareunia, scarification and contraction, fistula formation, extrusion and recurrence of vaginal wall prolapse.Perforations or lacerations of vessels, nerves, bladder, bowel, rectum, or any viscera may occur during needle passage." 1994, 2348, 2371, 2993 = "nl".
 
Event Description
It was reported by the patient's attorney that as a result of having the product implanted the patient has experienced pain, suffering, disability and impairment.
 
Manufacturer Narrative
1750="l" 1928, 2275, 1888, 2119="nl" h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
Per additional information received on (b)(6) 2021, the patient experienced mesh exposure, erosion, recurrent stress urinary incontinence, hypermobile urethra, occasional dyspareunia, difficulty with chronic urinary urgency, spotting, bleeding, recurrent vaginal pain, urinary retention and required additional surgical and non-surgical interventions.
 
Event Description
Per additional information received via medical records on 10-jan-2024, the patient had experienced mesh exposure, recurrent stress urinary incontinence, hypermobile urethra, urinary urgency, rare urgency incontinence and occasional dyspareunia, spotting, recurrent vaginal pain, urinary retention, vaginal bleeding, vaginal mesh erosion and required additional surgical non-surgical treatment.
 
Manufacturer Narrative
2519, 2564, 3191 ="nl".H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
Type of Device
AVAULTA PLUS® BIOSYNTHETIC SUPPORT SYSTEM - ANTERIOR
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key11704187
MDR Text Key248835124
Report Number1018233-2021-80032
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 01/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/30/2010
Device Catalogue Number486101
Device Lot NumberCVSF0021
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Device Age4 MO
Event Location Hospital
Initial Date Manufacturer Received 04/14/2021
Initial Date FDA Received04/21/2021
Supplement Dates Manufacturer Received06/11/2021
01/10/2024
Supplement Dates FDA Received06/18/2021
01/30/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/27/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age45 YR
Patient SexFemale
Patient Weight77 KG
-
-